Published in TB and Outbreaks Week, May 28th, 2002
DVC's trial is the largest study conducted to date that compares a smallpox vaccine, developed through state-of-the-art large-scale cell culture technology, to the previously licensed vaccine (Dryvax), which is currently in limited supply.
The phase I trial will be conducted at the University of Kentucky Chandler Medical Center. Students at the university and adults living in the Lexington area who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week